LATESHA WILLIAMS: Open Payments
NPI 1295343028 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 40 payments from 12 companies in 2025. Trend: 2023 $453 · 2024 $533 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 9 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 5 | $90 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| ABBVIE INC. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| Lundbeck LLC | 2 | $45 |
| Tris Pharma Inc | 2 | $34 |
Products named: Qelbree, TRINTELLIX, SPRAVATO, Auvelity, FANAPT, CAPLYTA, VRAYLAR, COBENFY.
Industry payments across MS — which companies pay providers there.
